Teva Pharmaceutical Industries (TEVA) Return on Capital Employed Growth (1y) (2010 - 2026)
Teva Pharmaceutical Industries (TEVA) Return on Capital Employed Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.85 Bn | 32.11 Bn | 1.97 Bn | 696.00 |
| 3 | Zoetis | 32.48 Bn | 30.54 Bn | 1.62 Bn | -507.00 |
| 4 | Takeda Pharmaceutical | 27.52 Bn | 23.46 Bn | 4.39 Bn | -723.00 |
| 5 | United Therapeutics | 23.16 Bn | 21.01 Bn | 648.10 Mn | 89.00 |
| 6 | RedHill Biopharma | 21.76 Bn | 21.76 Bn | - | - |
| 7 | Viatris | 20.33 Bn | 18.53 Bn | 1.16 Bn | 944.00 |
| 8 | Neurocrine Biosciences | 17.74 Bn | 16.43 Bn | 800.70 Mn | 448.00 |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn | 1,195.00 |
| 10 | Vireo Growth | 10.51 Bn | 10.36 Bn | 59.30 Mn | -679.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 696.00 |
| Dec 31, 2025 | 912.00 |
| Sep 30, 2025 | 467.00 |
| Jun 30, 2025 | 24.00 |
| Mar 31, 2025 | 79.00 |
| Dec 31, 2024 | -251.00 |
| Sep 30, 2024 | 578.00 |
| Jun 30, 2024 | 679.00 |
| Mar 31, 2024 | 527.00 |
| Dec 31, 2023 | 814.00 |
| Sep 30, 2023 | -54.00 |
| Jun 30, 2023 | -101.00 |
| Mar 31, 2023 | -608.00 |
| Dec 31, 2022 | -1,140.00 |
| Sep 30, 2022 | -908.00 |
| Jun 30, 2022 | 526.00 |
| Mar 31, 2022 | 1,042.00 |
| Dec 31, 2021 | 1,432.00 |
| Sep 30, 2021 | 1,509.00 |
| Jun 30, 2021 | -901.00 |